Skip to main content
. Author manuscript; available in PMC: 2013 Mar 25.
Published in final edited form as: J Pharm Biomed Anal. 2012 Jan 16;62:140–148. doi: 10.1016/j.jpba.2012.01.008

Table 6.

Assessment of accuracy and precision from quality control samples in porcine plasma

Table 6A Irinotecan

Nominal
(ng/mL)
GMa
(ng/mL)
S.D.
(ng/mL)
DEV
(%)
BRP
(%)
WRP
(%)
n
15 16.7 0.487 11.4 - 3.12 20
150 159.5 7.14 6.32 - 4.64 20
750 758.8 19.5 1.17 1.54 2.18 20
5000 5134 172.3 2.70 1.77 2.97 20

Table 6B SN38

Nominal
(ng/mL)
GMa
(ng/mL)
S.D.
(ng/mL)
DEV
(%)
BRP
(%)
WRP
(%)
n

1.5 1.54 0.080 2.53 4.07 3.82 20
15 15.7 0.853 4.95 4.76 3.38 20
75 78.3 2.52 4.38 2.32 2.48 20

Table 6C SN38-G

Nominal
(ng/mL)
GMa
(ng/mL)
S.D.
(ng/mL)
DEV
(%)
BRP
(%)
WRP
(%)
n

1.5 1.54 0.063 2.68 - 4.16 20
15 14.9 0.552 −0.94 - 3.83 20
75 75.9 3.62 1.25 3.13 3.87 20
a

Abbreviations: GM, grand mean; S.D., standard deviation; DEV, percent deviation from nominal value; WRP, within-run precision; BRP, between-run precision; n, total number of replicate observations within the validation runs.

*

A hyphen indicates MSwit>MSbet, thus BRP cannot be calculated and it was concluded that no additional variation was observed as a result of performing the assay in different runs.

a

Five samples at each concentration were run on four different occasions (n=20).